Jane Rabbitt

2.0k total citations
29 papers, 1.5k citations indexed

About

Jane Rabbitt is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jane Rabbitt has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Jane Rabbitt's work include Glioma Diagnosis and Treatment (26 papers), Brain Metastases and Treatment (13 papers) and Cancer Treatment and Pharmacology (4 papers). Jane Rabbitt is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Brain Metastases and Treatment (13 papers) and Cancer Treatment and Pharmacology (4 papers). Jane Rabbitt collaborates with scholars based in United States and Portugal. Jane Rabbitt's co-authors include Michael D. Prados, Kathleen R. Lamborn, Susan M. Chang, Margaretta Page, Mary Malec, Michael S. B. Edwards, Nicholas Butowski, Penny K. Sneed, William M. Wara and Michael Prados and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of neurosurgery.

In The Last Decade

Jane Rabbitt

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Rabbitt United States	17	1.1k	474	437	408	290	29	1.5k
Janet Bruner United States	12	1.1k 1.0×	648 1.4×	420 1.0×	290 0.7×	233 0.8×	22	1.5k
Laëtitia Padovani France	23	761 0.7×	404 0.9×	564 1.3×	315 0.8×	282 1.0×	86	1.7k
Brian Thiessen Canada	16	687 0.6×	295 0.6×	412 0.9×	261 0.6×	244 0.8×	32	1.2k
Jordonna Fulop United States	2	929 0.8×	292 0.6×	441 1.0×	294 0.7×	280 1.0×	2	1.6k
Émeline Tabouret France	23	1.0k 0.9×	604 1.3×	401 0.9×	317 0.8×	334 1.2×	103	1.8k
Ricardo Yayá Spain	11	888 0.8×	655 1.4×	411 0.9×	200 0.5×	209 0.7×	26	1.5k
Joohee Sul United States	17	912 0.8×	565 1.2×	365 0.8×	197 0.5×	328 1.1×	26	1.7k
Maryline Barrié France	18	1.5k 1.4×	824 1.7×	346 0.8×	349 0.9×	348 1.2×	53	1.9k
Stéphanie Cartalat‐Carel France	18	1.2k 1.0×	667 1.4×	268 0.6×	473 1.2×	231 0.8×	38	1.7k
Lynn S. Ashby United States	20	1.1k 0.9×	361 0.8×	304 0.7×	348 0.9×	196 0.7×	46	1.6k

Countries citing papers authored by Jane Rabbitt

Since Specialization

Citations

This map shows the geographic impact of Jane Rabbitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Rabbitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Rabbitt more than expected).

Fields of papers citing papers by Jane Rabbitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Rabbitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Rabbitt. The network helps show where Jane Rabbitt may publish in the future.

Co-authorship network of co-authors of Jane Rabbitt

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Rabbitt. A scholar is included among the top collaborators of Jane Rabbitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Rabbitt. Jane Rabbitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bush, Nancy Ann Oberheim, Jane Rabbitt, Mariza Daras, et al.. (2024). CTIM-31. PRELIMINARY RESULTS OF A PHASE II STUDY OF STEREOTACTIC RADIOSURGERY IN CONJUNCTION WITH THE PD-1 INHIBITOR PEMBROLIZUMAB FOR THE TREATMENT OF RECURRENT HIGH-GRADE MENINGIOMA. Neuro-Oncology. 26(Supplement_8). viii92–viii93. 1 indexed citations

Clarke, Jennifer, Annette M. Molinaro, Jane Rabbitt, et al.. (2017). A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemotherapy and Pharmacology. 79(3). 603–610. 38 indexed citations

Clarke, Jennifer, Annette M. Molinaro, Nicholas Butowski, et al.. (2012). A single-institution phase II trial of radiation (RT), temozolomide (TMZ), erlotinib, and bevacizumab for initial treatment of glioblastoma (GBM).. Journal of Clinical Oncology. 30(15_suppl). 2026–2026. 1 indexed citations

Parvataneni, Rupa, Mei‐Yin C. Polley, Kathleen R. Lamborn, et al.. (2011). Identifying the needs of brain tumor patients and their caregivers. Journal of Neuro-Oncology. 104(3). 737–744. 33 indexed citations

Liu, Raymond, Karla Solheim, Mei‐Yin C. Polley, et al.. (2008). Quality of life in low-grade glioma patients receiving temozolomide. Neuro-Oncology. 11(1). 59–68. 60 indexed citations

Butowski, Nicholas, Kathleen R. Lamborn, Susan Chang, et al.. (2007). Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. Molecular Cancer Therapeutics. 6. 1 indexed citations

Prados, Michael D., Kathleen R. Lamborn, Susan M. Chang, et al.. (2006). Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1. Neuro-Oncology. 8(1). 67–78. 172 indexed citations

Butowski, Nicholas, Michael D. Prados, Kathleen R. Lamborn, et al.. (2005). A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 61(5). 1454–1459. 46 indexed citations

Chang, Susan M., Kathleen R. Lamborn, Mary Malec, et al.. (2004). Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 60(2). 353–357. 117 indexed citations

10.

Chang, Susan M., Philip V. Theodosopoulos, Kathleen R. Lamborn, et al.. (2004). Temozolomide in the treatment of recurrent malignant glioma. Cancer. 100(3). 605–611. 67 indexed citations

11.

Prados, Michael D., William M. Wara, Penny K. Sneed, et al.. (2001). Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 49(1). 71–77. 108 indexed citations

12.

Levin, V. A., Kathleen R. Lamborn, William M. Wara, et al.. (2000). Phase II study of 6-thioguanine, procarbazine, dibromodulcitol,lomustine, and vincristine chemotherapy with radiotherapy for treatingmalignant glioma in children. Neuro-Oncology. 2(1). 22–28. 7 indexed citations

13.

Prados, Michael D., Michael S. B. Edwards, Susan M. Chang, et al.. (1999). Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a phase II study. International Journal of Radiation Oncology*Biology*Physics. 43(2). 279–285. 52 indexed citations

14.

Rabbitt, Jane, et al.. (1998). Selected complications in neuro-oncology patients. Seminars in Oncology Nursing. 14(1). 53–60. 8 indexed citations

15.

Chang, Susan M., Fred G. Barker, Stephen L. Huhn, et al.. (1998). High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma. Journal of Neuro-Oncology. 37(2). 169–176. 33 indexed citations

16.

Prados, Michael D., et al.. (1997). Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. Journal of Neuro-Oncology. 32(3). 235–241. 141 indexed citations

17.

Prados, Michael D., et al.. (1996). Intravenous Carboplatin for Recurrent Gliomas. American Journal of Clinical Oncology. 19(6). 609–612. 40 indexed citations

18.

Rabbitt, Jane, et al.. (1995). Issues in Metastatic Disease. Critical Care Nursing Clinics of North America. 7(1). 143–149. 1 indexed citations

19.

Warnick, Ronald E., et al.. (1994). A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. Journal of Neuro-Oncology. 19(1). 69–74. 81 indexed citations

20.

Petronio, Joseph, Michael S. B. Edwards, Michael Prados, et al.. (1991). Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. Journal of neurosurgery. 74(5). 701–708. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact